|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
ICD-10 (CM) Code and Descriptor
|
D72.110 |
Idiopathic hypereosinophilic syndrome [IHES]
|
D72110 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.36%
|
20.20%
|
7.47%
|
5.32%
|
3.17%
|
1.71%
|
1.96%
|
0.95%
|
0.82%
|
0.57%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D72.110*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
401
|
401
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
315
|
318
|
|
80053
|
COMPREHEN METABOLIC PANEL |
256
|
256
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
228
|
228
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
133
|
208
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
125
|
32,600
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
72
|
72
|
|
86140
|
C-REACTIVE PROTEIN |
37
|
37
|
|
82785
|
ASSAY OF IGE |
36
|
36
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
32
|
36
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
32
|
32
|
|
85652
|
RBC SED RATE AUTOMATED |
29
|
29
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
27
|
61
|
|
85610
|
PROTHROMBIN TIME |
27
|
27
|
|
J0517
|
INJ., BENRALIZUMAB, 1 MG |
26
|
780
|
|
82728
|
ASSAY OF FERRITIN |
25
|
25
|
|
85027
|
COMPLETE CBC AUTOMATED |
24
|
24
|
|
82607
|
VITAMIN B-12 |
23
|
23
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
21
|
25
|
|
86682
|
HELMINTH ANTIBODY |
20
|
20
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D72.110 related to the following DRG Codes:
814-816
|
